Collegium Pharmaceutical (COLL) and Paris Hilton are collaborating to share her personal experience living with attention-deficit/hyperactivity disorder, ADHD, and her treatment journey. Through this collaboration, Paris aims to reduce stigma and encourage others living with ADHD to speak with their healthcare provider about finding a treatment plan that works best for them.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL: